Product Information

PHENYLEPHRINE 2.5% EYE DROP is a generic product labeled by Caplin Steriles Limited, priced at $9.0847 per ML under NDC 65145014801. Its NADAC has been published 79 times since May 14, 2025.

FDA first approved this application on May 23, 2024. Its Orange Book therapeutic-equivalence code is AT.

PHENYLEPHRINE 2.5% EYE DROP

phenylephrine hydrochloride
$9.0847per ML

Strength

25 mg/mL

NDC

65145014801

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

PHENYLEPHRINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215183

FDA Approved

5/23/2024

TE Code

AT

On Market Since

1/23/2025

Pharmacological Classes

Adrenergic alpha1-Agonists
alpha-1 Adrenergic Agonist

Price Statistics

The NADAC for PHENYLEPHRINE 2.5% EYE DROP has been published 79 times since May 14, 2025, and over the history we have for it it has declined 29.8%. The table below summarizes its recorded NADAC range and movement.

Current price$9.0847 per ML
All-time high$12.9497 (May 14, 2025)
All-time low$8.5534 (Feb 18, 2026)
52-week high$9.9766
52-week low$8.5534
Median price$9.2043
Average price$10.2476
Largest weekly change-12.0% (Nov 19, 2025)
Weeks tracked79
Tracking sinceMay 14, 2025

Price History

1W

0.0%

1M

-2.2%

3M

-1.3%

6M

+0.0%

1Y

-19.8%

3Y

N/A

5Y

N/A

All

-29.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 88%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PHENYLEPHRINE 2.5% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for PHENYLEPHRINE 2.5% EYE DROP, manufactured by Caplin Steriles Limited, is $9.0847 per ML (NDC 65145014801), effective Nov 11, 2026.

How has the price of PHENYLEPHRINE 2.5% EYE DROP changed over time?

Over the history we have for it, the NADAC for PHENYLEPHRINE 2.5% EYE DROP has declined 29.8%. It has been tracked across 79 weekly CMS publications since May 14, 2025.

What are the highest and lowest recorded NADAC prices for PHENYLEPHRINE 2.5% EYE DROP?

Since May 14, 2025, the NADAC for PHENYLEPHRINE 2.5% EYE DROP has ranged from a low of $8.5534 (Feb 18, 2026) to a high of $12.9497 (May 14, 2025), with a median of $9.2043 per ML.

Are there cheaper alternatives to PHENYLEPHRINE 2.5% EYE DROP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PHENYLEPHRINE 2.5% EYE DROP, is $1.0784 per ML — about 88% below PHENYLEPHRINE 2.5% EYE DROP.

Who manufactures PHENYLEPHRINE 2.5% EYE DROP?

PHENYLEPHRINE 2.5% EYE DROP (NDC 65145014801) is labeled by Caplin Steriles Limited, and CMS classifies it as a generic product.